Status:
COMPLETED
Registry Study - Whipple at the Splenic Artery
Lead Sponsor:
Washington University School of Medicine
Conditions:
Pancreas Cancer
Eligibility:
All Genders
18-85 years
Brief Summary
The purpose of this study is to determine how effective Whipple at the Splenic Artery (WATSA).
Detailed Description
Primary The primary objective of this registry study is to collect clinical data from patients who undergo the WATSA procedure. Specific hypotheses to be tested are * To determine how effective Whip...
Eligibility Criteria
Inclusion
- Eligibility Criteria - Prospective Portion:
- Patient must have diagnosis of ductal adenocarcinoma of head and/or neck of pancreas, ampullary adenocarcinoma, or pancreatic neuroendocrine tumor confirmed by tissue diagnosis.
- Patient must be between 18 to 85 years of age.
- Patient must be a candidate for the WATSA procedure or have had the WATSA surgery performed within 1 year.
- Patient must be able to understand and willing to sign a written informed consent document.
- Eligibility Criteria - Retrospective Portion:
- Patient underwent WATSA procedure at our institution between 01/01/2009 and 12/31/2011.
Exclusion
Key Trial Info
Start Date :
September 20 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 16 2019
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT01155882
Start Date
September 20 2010
End Date
January 16 2019
Last Update
January 22 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington University School of Medicine
St Louis, Missouri, United States, 63110